Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion type Assertion NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_head.
- NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion description "[The odds ratios were 8.9 (95% CI 5.7 - 13.7) for hyperhomocysteinemia, 3.9 (95% CI 2.3 - 6.7) for anticardiolipin antibodies, 1.2 (95% CI 0.9 - 1.6) for MTHFR, 1.5 (95% CI 1.0 - 2.2) for factor V Leiden mutation and 1.6 (95% CI 0.8 - 3.2) for prothrombin gene mutation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_provenance.
- NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion evidence source_evidence_literature NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_provenance.
- NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion SIO_000772 15968383 NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_provenance.
- NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion wasDerivedFrom befree-2016 NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_provenance.
- NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_assertion wasGeneratedBy ECO_0000203 NP500331.RAz3S0LB8YraUlzp47jSFo9IF6iLgH5HYp5d_Ysb8Q1JQ130_provenance.